Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Manjula, Shamanna"'
Autor:
Manjula Shamanna, M Krishnakumar, Lakshminarayana Reddy, B K Srikanth, Sunita Biradar, Deepak D Mariguddi
Publikováno v:
Pediatric Health, Medicine and Therapeutics. 10:5-11
Objective Thrombocytopenia in dengue fever (DF) is a well-known complication in both adults and pediatric subjects. Management of DF primarily includes symptomatic and intensive supportive care. There are studies available on the efficacy and safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a0d9672a0e2c3abdb609a455feed1af
https://doi.org/10.2147/phmt.s176712
https://doi.org/10.2147/phmt.s176712
Autor:
M.K. Sudarshan, Manjula Shamanna, Gadey Sampath, Gonibeedu Manjunath Venkatesh, Gangaboraiah Bilugumba, Soma Subhra datta, Doddabele Hanumanthaiah Ashwathnarayana, B J Mahendra, Shampur Narayan Madhusudana
Publikováno v:
Human Vaccines. 6:721-724
Rabies continues to be a major public health problem in India. Nearly 17 million people are getting exposed to this disease every year. Therefore the need for effective post-exposure prophylaxis with safe and potent modern rabies vaccines continues t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af0cb7558e92515a8d6c67f78d54b3f7
https://doi.org/10.4161/hv.6.9.12216
https://doi.org/10.4161/hv.6.9.12216
Autor:
Tapas Ranjan Behra, Padinjaremattathil Thankappan Ullas, M.K. Sudarshan, Ranjit Mankeshwar, Gadey Sampath, Manjula Shamanna, S.N. Madhusudana, Durga Madhab Sathpathy, Gangaboraiah, Doddabele Hanumantaiah Ashwathnarayana, Haradana Halli Shankariah Ravish
Publikováno v:
Vaccine. 28:148-151
Rabies is a fatal but preventable disease. Cell culture vaccines (CCV) and purified duck embryo vaccines (PDEV) are currently recommended by WHO for post-exposure prophylaxis. In India, a PDEV (Vaxirab) is being manufactured and is in use since 2003.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cb74bc024a9d65c47888c8876ddf933
https://doi.org/10.1016/j.vaccine.2009.09.090
https://doi.org/10.1016/j.vaccine.2009.09.090
Autor:
Adarsh Gowda, Manjula Shamanna, P Shilpashree, Bilugumba Gangaboraiah, Ashok Kumar Jaiswal, B C Sharath Kumar, NT Madan Mohan
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology
Introduction Melasma is one of the commonly reported pigmentory disorders in the Indian population. Numerous therapeutic modalities are available. However, very few have produced complete satisfactory response. 4-n-Butylresorcinol 0.3% cream has rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a49e36722b4ad2efb0975f00a3a691b
https://www.dovepress.com/assessment-of-efficacy-safety-and-tolerability-of-4-n-butylresorcinol--peer-reviewed-article-CCID
https://www.dovepress.com/assessment-of-efficacy-safety-and-tolerability-of-4-n-butylresorcinol--peer-reviewed-article-CCID
Autor:
Gonibeedu Manjunatah Venkatesh, Soma Subhra datta, Manjula Shamanna, Gadey Sampath, M.K. Sudarshan, Shampur Narayan Madhusudana, Gangaboraiah Bilagumba, Doddabele Hanumanthaiah Ashwathnarayana, B J Mahendra, Kader Muhamuda
Publikováno v:
Vaccine. 25:8405-8409
Purified duck embryo vaccine (PDEV, Vaxirab) for rabies prophylaxis is now indigenously manufactured in India under technology transfer from Berna Biotech who made the original PDEV (Lyssavac). In the present study we have compared the two vaccines i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16a110c442e8e173ac69439cddc23855
https://doi.org/10.1016/j.vaccine.2007.10.002
https://doi.org/10.1016/j.vaccine.2007.10.002
Autor:
M.K. Sudarshan, Shampur Narayan Madhusudana, Veena Vijayashankar, H S Ravish, Gangaboraiah Andanaiah, Annadani R Rachana, Doddabele Ha Narayana, Belludi Yajaman Ashwin, Manjula Shamanna
Publikováno v:
Human vaccinesimmunotherapeutics. 10(8)
The affordability to rabies vaccine for intramuscular administration in post exposure prophylaxis is a major constraint. Therefore, in countries, where there are financial constraints, World Health Organization recommends intradermal rabies vaccinati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4be94f542e09a9f15c64553670259fd2
https://pubmed.ncbi.nlm.nih.gov/25424951
https://pubmed.ncbi.nlm.nih.gov/25424951
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Doddabele Hanumantaiah Ashwathnarayana, Shampur Narayana Madhusudana, Gadey Sampath, Durga Madhab Sathpathy, Ranjit Mankeshwar, Haradana Halli Shankariah Ravish, Padinjaremattathil Thankappan Ullas, Tapas Ranjan Behra, Mysore Kalappa Sudarshan, null Gangaboraiah, Manjula Shamanna
Publikováno v:
Vaccine. 28:2575
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14ea9ae3e6666924030ee4136e295978
https://doi.org/10.1016/j.vaccine.2010.01.048
https://doi.org/10.1016/j.vaccine.2010.01.048
Autor:
Ashwath Narayana, Doddabele Hanumanthaiah, Narayana Madhusudana, Shampur, Sampath, Gadey, Madhab Tripathy, Radhe, Kalappa Sudarshan, Mysore, Gangaboraiah, Shankaraiah Ravish, Haradanahalli, Madhab Satapathy, Durga, Gowda, Giriyanna, Holla, Ramesh, Yajman Ashwin, Belludi, Padhi, Asutosh, Manjula, Shamanna, Maganlal Patel, Pradip
Publikováno v:
Human Vaccines & Immunotherapeutics; Jan2014, Vol. 10 Issue 1, p1-6, 6p